FDA Approves Secukinumab for Adults With HS
This marks the second FDA-approved agent for the condition, and the first IL-17A inhibitor.
Source: medscape.com
Page 27 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Linical Studies Today - Breaking & Trending Today
United Therapeutics Corp (UTHR) Reports 18% YoY Revenue Growth in Q3 2023
Net income also sees a 12% increase, reaching $267.6 million
Source: yahoo.com
¬¬Study Spotlights Features of Infantile Hemangioma Subset
Detailed reports on this patient population are sparse and limited to case reports and small case series.
Source: medscape.com
Latest Evidence on Hyperthyroidism Symptoms, Treatment
If left untreated, hyperthyroidism can lead to cardia arrhythmias and osteoporosis. A new review summarizes recent evidence regarding the treatment of hyperthyroidism.
Source: medscape.com
First-in-Class Regenerative Therapeutic for AD Promising
Allopregnanolone has the potential to delay neurodegeneration in early Alzheimer's disease by promoting endogenous systems of renewal and repair, early testing shows.
Source: medscape.com